Cronos Group Inc. (CRON) Stock Price & Analysis

Cronos Group Inc. (CRON) is trading at USD 3.34, down 3.19% today, as of October 23, 2026 at 16:59 UTC (US market open; quotes may be delayed), according to Nexqual market data.

CRON last closed at USD 3.34; today's session has ranged USD 3.3–3.43 on volume of 516,420 shares. Market capitalization is —, with a 52-week range of USD 2.28–3.61 (NGM). Source: Nexqual, retrieved October 23, 2026 at 17:02 UTC.

Also available as compact Markdown for AI agents: nexqual.com/CRON.md

Key facts (CRON)

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CRON)

USDFY2021FY2022FY2023FY2024FY2025TTM
Revenue$64.6M$86.7M$87.2M$118M$147M$179M
Gross profit-$17.6M$15.4M$11.9M$25.2M$62.8M—
Operating income-$292M-$111M-$84.8M-$76.5M-$17.4M-$2.4M
Net income-$396M-$169M-$74.0M$41.1M-$9.4M$70.0M
EPS (diluted)-$1.07-$0.45-$0.19$0.11-$0.02—
Free cash flow-$165M-$92.4M-$45.3M$6.4M$149K$49.8M
Gross margin-27.3%17.8%13.7%21.4%42.8%—
Operating margin-452.2%-128.4%-97.2%-65.1%-11.9%-1.4%
Net margin-613.5%-194.5%-84.8%34.9%-6.4%39.1%
Revenue growth+38.2%+34.4%+0.6%+34.8%+24.6%—
Cash + short-term investments$1.00B$878M$862M$859M$832M—

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (CRON)

P/E at fiscal year-ends: Dec 2024 19.0x.

Analysts (CRON)

Rating changes, last 120 days:

DateFirmActionRatingPrice target
2026-10-13Zuanic & AssociatesInitiatedOverweight

Total return (dividends reinvested) (CRON)

1Y (from 2025-10-23)5Y (from 2021-10-25)
Total return+34.5%-35.7%
S&P 500 (SPY)+14.6%+77.3%
Per year+34.5%-8.5%
Volatility (annualized)39.3%45.9%
Max drawdown-26.9% (Dec 2025→Mar 2026)-73.3% (Nov 2021→Jun 2023)

CRON revenue by product line (quarter ended Jun 30, 2026)

LineRevenueShare of totalYoY
Cannabis flower$39.2M74.0%+56.7%
Cannabis extracts$13.8M26.0%+64.8%
Other$19,0000.0%-72.9%
Total revenue$53.0M100%—

CRON revenue by region (quarter ended Jun 30, 2026)

LineRevenueShare of totalYoY
Canada$28.7M54.2%+49.9%
Israel$15.0M28.3%+60.2%
Other countries$9.3M17.5%+88.3%
Total revenue$53.0M100%—

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

CRON suppliers, customers and competitors (named in its 10-K)

RelationshipCompanySentence in the filing
SupplierCronos Growing Company“•our ability to acquire raw materials from suppliers, including Cronos Growing Company Inc. ("Cronos GrowCo"), and the costs and timing associated therewith;”
PartnerManitoba Liquor & Lotteries“We have entered into supply arrangements with all provinces in Canada (where the relevant provincial body is the sole wholesale distributor of cannabis products in the province, except for Manitoba where we have also entered into a distribution agreement with a Manitoba Liquor & Lotteries Corporation authorized cannabis distributor) and the Yukon territory and with private retailers in Saskatchewan.”
PartnerCronos and Ginkgo Bioworks Holdings“We account for the cannabinoid exclusive licenses originating from the Ginkgo Strategic Partnership as definite-lived intangible assets in accordance with the acquisition method of accounting.”
PartnerHigh Tide Inc. (HITI)“See Note 6 "Loans Receivable, net" for discussion of the loan receivable recognized as part of the agreement with High Tide.”

Quoted from the company's 10-K filed Feb 26, 2026.

Companies that name CRON in their SEC reports

Relationship to CRONCompanyFilingSentence
partnerHigh Tide Inc. (HITI)40-F Jan 29, 2026“•the intention of the Corporation to complete any additional offering of securities of the Corporation and the aggregate amount of the total proceeds that the Corporation will receive pursuant to a $19,000,000 senior secured credit facility with Connect First Credit Unition Ltd. ("connectFirst"), with an initial 5- year term, at connectFirst's floor interest rate (the "September 2022 Credit Facility"), the loan ag…”

CRON customer concentration

In the period ended Dec 31, 2025, a single direct customer accounted for 43% of revenue, per the company's 10-K filed Feb 26, 2026. The company does not name it.

CRON company outlook (results filed Aug 6, 2026)

Quoted word-for-word from the SEC 8-K results press release.

CRON analyst estimates and revisions

PeriodEPS estimate90 days agoChangeRevenue estimateAnalysts
Current quarter (ends Sep 2026)$0.05$0.00—$73.4M3
Next quarter (ends Dec 2026)$0.06$0.00—$89.6M3
Current fiscal year (ends Dec 2026)$0.24$0.00—$301.6M5
Next fiscal year (ends Dec 2027)$0.26$0.00—$390.5M5

Key Statistics (as of October 23, 2026 at 17:02 UTC)

PriceUSD 3.34
Change▼ 3.19% (down)
Previous CloseUSD 3.34
OpenUSD 3.34
Day RangeUSD 3.3 – 3.43
52-Week RangeUSD 2.28 – 3.61
Volume516,420 shares
Market Cap—
ExchangeNGM

Technical Analysis (CRON)

Nexqual's technical model rates CRON "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of October 23, 2026 at 17:02 UTC.

Overall SignalSTRONG BUY
RSI (14)56.29 (neutral)
vs SMA50Above (USD 3.29)
MACD0.02 (positive)

Earnings (CRON)

Next Earnings Date2026-11-05
Revenue Estimate$73.39M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD 0.13 vs est 0.01 ▲ beat
2026-03-31USD 0.05 vs est 0.01 ▲ beat
2025-12-31USD 0 vs est 0.02 ▼ miss
2025-09-30USD 0.1 vs est 0 ▲ beat

Source: Nexqual, October 23, 2026 at 17:02 UTC.

Financials & Fundamentals (CRON)

Total Revenue$179.09M
Revenue Growth (latest quarter, YoY)+58.40%
Gross Margin+43.02%
Operating Margin+15.44%
Profit Margin+39.08%
ROE+7.05%
Debt / Equity0
Current Ratio16.18
Total Cash$797.02M
Total Debt$1.29M

Source: Nexqual, October 23, 2026 at 17:02 UTC.

Ownership (CRON)

Insider Ownership+49.14%
Institutional Ownership+15.53%
Shares Outstanding368.41M
Float186.99M
Short % of Float+1.84%

Source: Nexqual, October 23, 2026 at 17:02 UTC.

From Cronos Group Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)

Partnerships

Legal & Regulatory Risks (Item 1A, quoted)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
CGCCanopy Growth CorporationUSD 0.67▲ 0.48%
ACBAurora Cannabis Inc.USD 3.9▼ 1.89%
TLRYTilray Brands, Inc.USD 2.84▼ 3.24%
OGIOrganigram Global Inc.USD 0.93▼ 0.86%
GTBIFGreen Thumb Industries Inc.USD 6.37▼ 2%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 17:02 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt